The effect of calcium load and the calcium channel blocker verapamil on gentamicin nephrotoxicity in rats

B. H. Ali, A. A. Al-Qarawi, H. M. Mousa

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Gentamicin (GM) is used against serious and life-threatening Gram negative infections. However its use is limited by the occurrence of nephrotoxicity. Reports on the interaction between GM nephrotoxicity and calcium (Ca2+) or Ca blockers are conflicting. Therefore, in the present work we assessed the effect of treatment of rats with graded doses of calcium carbonate, CaCO3 (0.25, 0.5 or 1.0 g/kg) orally, or the Ca2+ channel blocker verapamil (1.75, 3.5 or 7.0 mg/ kg) intramuscularly (i.m.), on the nephrotoxicity induced by concomitant i.m. treatment with GM (80 mg /kg/day for 6 days). Nephrotoxicity was evaluated histopathologically by light microscopy and biochemically by measuring the concentrations of urea and creatinine in plasma, reduced glutathione (GSH), lipid peroxidation and superoxide dismutase (SOD) activity in kidney cortex. The results indicated that the administration of CaCO3 produced a dose-dependent amelioration in the biochemical indices of nephrotoxicity in plasma and renal cortex, which was significant at the two higher doses used. The histological picture of the renal proximal tubules followed a similar pattern. Treatment with verapamil induced a dose-dependent potentiation in the biochemical parameters of nephrotoxicity that was significant only at the highest dose used (7 mg/kg). This dose also exacerbated the GM-induced histological necrosis. The above interactions may be clinically relevant in patients treated concurrently with these agents.

Original languageEnglish
Pages (from-to)1843-1847
Number of pages5
JournalFood and Chemical Toxicology
Volume40
Issue number12
DOIs
Publication statusPublished - Dec 1 2002

Fingerprint

calcium channel blockers
nephrotoxicity
verapamil
Calcium Channel Blockers
gentamicin
Verapamil
Gentamicins
Rats
Calcium
calcium
rats
dosage
kidneys
Plasmas
Kidney Cortex
Proximal Kidney Tubule
Calcium Carbonate
cortex
Lipid Peroxidation
Superoxide Dismutase

Keywords

  • Calcium
  • Calcium channel blocker
  • Gentamicin
  • Nephrotoxicity
  • Verapamil

ASJC Scopus subject areas

  • Food Science
  • Toxicology

Cite this

The effect of calcium load and the calcium channel blocker verapamil on gentamicin nephrotoxicity in rats. / Ali, B. H.; Al-Qarawi, A. A.; Mousa, H. M.

In: Food and Chemical Toxicology, Vol. 40, No. 12, 01.12.2002, p. 1843-1847.

Research output: Contribution to journalArticle

@article{dfaedec443db4d49b52c38c26c3066f2,
title = "The effect of calcium load and the calcium channel blocker verapamil on gentamicin nephrotoxicity in rats",
abstract = "Gentamicin (GM) is used against serious and life-threatening Gram negative infections. However its use is limited by the occurrence of nephrotoxicity. Reports on the interaction between GM nephrotoxicity and calcium (Ca2+) or Ca blockers are conflicting. Therefore, in the present work we assessed the effect of treatment of rats with graded doses of calcium carbonate, CaCO3 (0.25, 0.5 or 1.0 g/kg) orally, or the Ca2+ channel blocker verapamil (1.75, 3.5 or 7.0 mg/ kg) intramuscularly (i.m.), on the nephrotoxicity induced by concomitant i.m. treatment with GM (80 mg /kg/day for 6 days). Nephrotoxicity was evaluated histopathologically by light microscopy and biochemically by measuring the concentrations of urea and creatinine in plasma, reduced glutathione (GSH), lipid peroxidation and superoxide dismutase (SOD) activity in kidney cortex. The results indicated that the administration of CaCO3 produced a dose-dependent amelioration in the biochemical indices of nephrotoxicity in plasma and renal cortex, which was significant at the two higher doses used. The histological picture of the renal proximal tubules followed a similar pattern. Treatment with verapamil induced a dose-dependent potentiation in the biochemical parameters of nephrotoxicity that was significant only at the highest dose used (7 mg/kg). This dose also exacerbated the GM-induced histological necrosis. The above interactions may be clinically relevant in patients treated concurrently with these agents.",
keywords = "Calcium, Calcium channel blocker, Gentamicin, Nephrotoxicity, Verapamil",
author = "Ali, {B. H.} and Al-Qarawi, {A. A.} and Mousa, {H. M.}",
year = "2002",
month = "12",
day = "1",
doi = "10.1016/S0278-6915(02)00167-9",
language = "English",
volume = "40",
pages = "1843--1847",
journal = "Food and Chemical Toxicology",
issn = "0278-6915",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - The effect of calcium load and the calcium channel blocker verapamil on gentamicin nephrotoxicity in rats

AU - Ali, B. H.

AU - Al-Qarawi, A. A.

AU - Mousa, H. M.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Gentamicin (GM) is used against serious and life-threatening Gram negative infections. However its use is limited by the occurrence of nephrotoxicity. Reports on the interaction between GM nephrotoxicity and calcium (Ca2+) or Ca blockers are conflicting. Therefore, in the present work we assessed the effect of treatment of rats with graded doses of calcium carbonate, CaCO3 (0.25, 0.5 or 1.0 g/kg) orally, or the Ca2+ channel blocker verapamil (1.75, 3.5 or 7.0 mg/ kg) intramuscularly (i.m.), on the nephrotoxicity induced by concomitant i.m. treatment with GM (80 mg /kg/day for 6 days). Nephrotoxicity was evaluated histopathologically by light microscopy and biochemically by measuring the concentrations of urea and creatinine in plasma, reduced glutathione (GSH), lipid peroxidation and superoxide dismutase (SOD) activity in kidney cortex. The results indicated that the administration of CaCO3 produced a dose-dependent amelioration in the biochemical indices of nephrotoxicity in plasma and renal cortex, which was significant at the two higher doses used. The histological picture of the renal proximal tubules followed a similar pattern. Treatment with verapamil induced a dose-dependent potentiation in the biochemical parameters of nephrotoxicity that was significant only at the highest dose used (7 mg/kg). This dose also exacerbated the GM-induced histological necrosis. The above interactions may be clinically relevant in patients treated concurrently with these agents.

AB - Gentamicin (GM) is used against serious and life-threatening Gram negative infections. However its use is limited by the occurrence of nephrotoxicity. Reports on the interaction between GM nephrotoxicity and calcium (Ca2+) or Ca blockers are conflicting. Therefore, in the present work we assessed the effect of treatment of rats with graded doses of calcium carbonate, CaCO3 (0.25, 0.5 or 1.0 g/kg) orally, or the Ca2+ channel blocker verapamil (1.75, 3.5 or 7.0 mg/ kg) intramuscularly (i.m.), on the nephrotoxicity induced by concomitant i.m. treatment with GM (80 mg /kg/day for 6 days). Nephrotoxicity was evaluated histopathologically by light microscopy and biochemically by measuring the concentrations of urea and creatinine in plasma, reduced glutathione (GSH), lipid peroxidation and superoxide dismutase (SOD) activity in kidney cortex. The results indicated that the administration of CaCO3 produced a dose-dependent amelioration in the biochemical indices of nephrotoxicity in plasma and renal cortex, which was significant at the two higher doses used. The histological picture of the renal proximal tubules followed a similar pattern. Treatment with verapamil induced a dose-dependent potentiation in the biochemical parameters of nephrotoxicity that was significant only at the highest dose used (7 mg/kg). This dose also exacerbated the GM-induced histological necrosis. The above interactions may be clinically relevant in patients treated concurrently with these agents.

KW - Calcium

KW - Calcium channel blocker

KW - Gentamicin

KW - Nephrotoxicity

KW - Verapamil

UR - http://www.scopus.com/inward/record.url?scp=0036888147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036888147&partnerID=8YFLogxK

U2 - 10.1016/S0278-6915(02)00167-9

DO - 10.1016/S0278-6915(02)00167-9

M3 - Article

VL - 40

SP - 1843

EP - 1847

JO - Food and Chemical Toxicology

JF - Food and Chemical Toxicology

SN - 0278-6915

IS - 12

ER -